Diagnostics Solutions Strategic Priorities slide image

Diagnostics Solutions Strategic Priorities

New systems launches in 2021 Enabling comparable results in different size laboratories Serum Work Area solutions 2021 cobasⓇ pure¹ cobasⓇ pro Throughput 2021 cobasⓇ pro (high throughput) Improved outcomes Family concept addressing needs of all lab sizes to increase access Roche Molecular solutions cobas® 58001 2021 cobas® 6800 cobas® 8800 1 Currently in development and not commercially available www. Increased profitability Up to 50% lower SMCs per test and 20% lower service cost More sustainable Up to 80% less plastic waste per test 42
View entire presentation